Optellum Virtual Nodule Clinic vs ContaCT
AI Verdict
Choose Optellum Virtual Nodule Clinic if…
Choose Optellum Virtual Nodule Clinic if your primary need is a specialized, AI-driven solution for the comprehensive management of lung nodules, aiming for early lung cancer diagnosis and risk stratification. This tool is ideal for institutions seeking to optimize their lung nodule program with automated patient discovery, workflow management, and clinically validated prediction scores for malignancy risk.
View Optellum Virtual Nodule Clinic →Choose ContaCT if…
Choose ContaCT by Viz.ai if your organization requires a broad, AI-powered platform for accelerating the detection of multiple acute conditions and streamlining care coordination across various specialties. This solution is best suited for hospitals focused on improving response times for critical diagnoses like stroke, pulmonary embolism, or intracranial hemorrhage, by enabling real-time alerts and secure mobile communication among care teams.
View ContaCT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Optellum Virtual Nodule Clinic | ContaCT |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based |
| Deployment | On-premise or private cloud options within hospital datacenter. | Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ContaCTViz.ai offers a mobile application for specialists to view images and communicate, along with real-time alerts, which provides greater flexibility and immediate access for critical care scenarios. Optellum primarily offers a web application with dashboards, which is suitable for workflow management but lacks the explicit mobile-first approach for urgent situations.
Clinical Value
Optellum Virtual Nodule ClinicOptellum provides a highly specialized, FDA-cleared AI-powered Lung Cancer Prediction (LCP) score and uses NLP for patient discovery, offering a direct and quantifiable diagnostic aid for early lung cancer. While Viz.ai covers a broader range of acute conditions, Optellum's deep specialization and specific risk stratification for lung cancer demonstrate a focused and impactful clinical value within its domain.
Pricing & Value
Optellum Virtual Nodule ClinicOptellum explicitly details clear reimbursement pathways with Category III CPTu00ae codes (0721T) and a Medicare payment assignment of $650.50 in 2025, providing a transparent and quantifiable return on investment for healthcare providers. Viz.ai's subscription-based pricing is variable and lacks similar transparency regarding direct reimbursement mechanisms.
Enterprise Readiness
ContaCTViz.ai demonstrates strong enterprise readiness with its proven deployment in over 1,700 hospitals globally, indicating robust integration capabilities and operational maturity at scale. While Optellum offers deployment flexibility with on-premise or private cloud options, Viz.ai's extensive global footprint highlights its established ability to integrate and operate within diverse enterprise environments.
Innovation
ContaCTViz.ai presents a broader, more impactful innovation as a 'pioneering AI-powered care coordination platform' that offers real-time, multi-disease detection and mobile-first communication across various acute conditions. This platform approach streamlines entire clinical workflows, representing a significant advancement beyond a single diagnostic aid.
Support & Docs
ContaCTViz.ai provides extensive and transparent support resources, including a comprehensive Knowledge Base, 24/7 urgent phone support, and a Trust Center for detailed security and compliance documentation. Optellum offers a customer success team for integration and a learning center, but its direct support channels and documentation transparency are less detailed in publicly available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Optellum Virtual Nodule Clinic | ContaCT |
|---|---|---|
| Name | Optellum Virtual Nodule Clinic | ContaCT |
| Company | Optellum Ltd. | Viz.AI |
| Description | FDA-cleared, AI-powered clinical decision support software for early lung cancer diagnosis and comprehensive lung nodule management, integrating seamlessly with EHR and PACS. | Viz.ai is a pioneering AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows. With multiple FDA clearances, including the initial Viz.AI Contact application for stroke, it helps ensure patients receive timely treatment across over 1,700 hospitals globally. |
| Primary Clinical Focus | Early lung cancer diagnosis and lung nodule management | Disease detection and care coordination, specifically mentioning stroke (LVO, ICH), HCM, PE, Aneurysm |
| Key Features (AI-powered) | Lung Cancer Prediction (LCP) score for malignancy risk assessment, Patient Discovery AI to identify nodules from radiology reports using NLP | Disease detection (LVO, ICH, HCM, PE, Aneurysm), Real-time AI-powered alerts and notifications |
| Integration | Seamless EHR and PACS integration (HL7, DICOM) | Integration with PACS and EHR systems |
Videos
Demos, reviews, and walkthroughs featuring Optellum Virtual Nodule Clinic and ContaCT.
Frequently Asked Questions
More Comparisons
More matchups featuring Optellum Virtual Nodule Clinic or ContaCT
Backers
Who funded each tool's parent company.